Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.

Nakajima A, Okanoue T, Hiasa Y, Takahashi H, Opuni K, Kosaka N, Nishida T, Sanyal AJ

Open source

DOI
10.1007/s00535-026-02507-0
Published
2026 Aug 28
Container
Journal of gastroenterology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00535-026-02507-0,
  title = {Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.},
  author = {Nakajima A and Okanoue T and Hiasa Y and Takahashi H and Opuni K and Kosaka N and Nishida T and Sanyal AJ},
  year = {2026},
  journal = {Journal of gastroenterology},
  doi = {10.1007/s00535-026-02507-0},
  url = {https://doi.org/10.1007/s00535-026-02507-0}
}

RIS

TY  - JOUR
TI  - Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.
AU  - Nakajima A
AU  - Okanoue T
AU  - Hiasa Y
AU  - Takahashi H
AU  - Opuni K
AU  - Kosaka N
AU  - Nishida T
AU  - Sanyal AJ
PY  - 2026
JO  - Journal of gastroenterology
DO  - 10.1007/s00535-026-02507-0
UR  - https://doi.org/10.1007/s00535-026-02507-0
ER  - 

APA

A, N., T, O., Y, H., H, T., K, O., N, K., T, N., & AJ, S. (2026). Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial.. Journal of gastroenterology. https://doi.org/10.1007/s00535-026-02507-0

Source records